title: Effect of exendin (exenatide)--GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model.
abstract: Exenatide or Exendin-4 is a 39-amino acid agonist of the glucagon like peptide (GLP-1) receptor approved for the adjunctive treatment for type 2 diabetes. Recent reports suggest that GLP-1 agonists may also have distant effects including C-cell thyroid hyperplasia. The aim of this study was to evaluate the effect of exendin-4 on the thyroid and parathyroid cells in a rat model. Rat thyroids were stained for calcitonin, H&E and for carcinoembryonic antigen (CEA). Thyroid C-cell hyperplasia was graded on H&E stained slides using cell size and secretory granule numbers, morphological features of the parathyroid glands and the serum calcium concentrations of the rats were also evaluated. Counts of stained cells/high power field and intensity of staining were recorded by two pathologists. Data were analyzed by ANOVA/post-tests. C cell hypertrophy was elevated in exenatide-treated vs. untreated animals (22.5 ± 8.7 vs. 10.5 ± 2.7 cells/HPF). CEA staining failed to show effects by exendin. Calcitonin staining was significantly elevated in exenatide treated controls (P<0.001). Parathyroid glands were histologically normal in both groups, and serum calcium levels were within normal range in all animals. In summary, exenatide was associated with C cell hyperplasia and increased calcitonin staining of thyroids, but was unrelated to CEA levels. These data raise important concerns about the effects of exenatide which, given its wide clinical use, should be clarified with urgency.
authors: Summer Medical Group, Gallatin, TN, USA. dbulchandani@yahoo.com
authors: Deepti
authors: D
authors: Bulchandani
authors: Jagdish S
authors: JS
authors: Nachnani
authors: Betty
authors: B
authors: Herndon
authors: Agostino
authors: A
authors: Molteni
authors: Muhammad H
authors: MH
authors: Pathan
authors: Tim
authors: T
authors: Quinn
authors: Hana A
authors: HA
authors: Hamdan
authors: Laura M
authors: LM
authors: Alba
authors: Leland
authors: L
authors: Graves
mesh_terms: D000818:Animals; D002116:Calcitonin / Q000378:metabolism; D002118:Calcium / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D000077270:Exenatide; D000067757:Glucagon-Like Peptide-1 Receptor; D008297:Male; D010280:Parathyroid Glands / Q000187:drug effects* / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018027:Receptors, Glucagon / Q000819:agonists*; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism*; D014688:Venoms / Q000494:pharmacology*
chemical_list: D002272:Carcinoembryonic Antigen; C000593835:Glp1r protein, rat; D000067757:Glucagon-Like Peptide-1 Receptor; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D002116:Calcitonin; D000077270:Exenatide; D002118:Calcium